trending Market Intelligence /marketintelligence/en/news-insights/trending/r_Gr5hELogqpt5IBqJv01g2 content esgSubNav
In This List

Recro Pharma raises close to $37M in stock offering

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Recro Pharma raises close to $37M in stock offering

Recro Pharma Inc. closed a public offering of 6,670,000 shares at $6 apiece to raise $36.9 million in net proceeds.

The funds will help Recro advance development of injectable meloxicam to treat moderate to severe postoperative pain.

Piper Jaffray & Co. was the sole book-running manager of the issue, with Janney Montgomery Scott and ROTH Capital Partners acting as co-managers.